GlassScriptPhysician profile
Nina Metcalfe
NPI 1487049565
$2,380.20
in general payments reported to CMS, 2019-2025
17 companies · $679 in 2025
The $679 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2023: $677 · 2024: $893 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,843 · Travel and Lodging: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,842.82 |
| Travel and Lodging | $405.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,074.54 | 2023-2025 | Interstim, Truclear |
| Boston Scientific Corporation | $415.07 | 2024-2025 | Axonics, Advantage System, Varithena Administration Pack |
| Sumitomo Pharma America, INC. | $258.60 | 2023-2025 | Gemtesa, Orgovyx, Myfembree |
| Medtronic USA, INC. | $131.73 | 2019 | |
| Abbvie INC. | $97.75 | 2024-2025 | |
| Astellas Pharma US INC | $86.88 | 2023-2024 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $57.26 | 2024 | Welireg, Keytruda |
| Evofem Biosciences, INC. | $39.19 | 2023 | Phexxi |
| Hologic Sales and Service, LLC | $32.08 | 2024 | Novasure |
| Janssen Biotech, INC. | $31.49 | 2024 | Akeega, Erleada |
| Convatec INC. | $30.49 | 2024 | |
| Tolmar, INC. | $28.31 | 2024 | |
| Pfizer INC. | $21.80 | 2023 | |
| Antares Pharma, INC. | $20.36 | 2024 | Xyosted |
| Femselect INC. | $20.35 | 2025 | Enplace |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $19.65 | 2023 | Desara |
| Coloplast Corp | $14.65 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Metcalfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.